Literature DB >> 14287841

PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961.

F O KELSEY.   

Abstract

Entities:  

Keywords:  ABNORMALITIES, DRUG-INDUCED; DRUG INDUSTRY; GERMANY; INFANT, NEWBORN; LEGISLATION, MEDICAL; PREGNANCY; PREGNANCY COMPLICATIONS; PUBLIC HEALTH ADMINISTRATION; THALIDOMIDE; TOXICOLOGIC REPORT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION

Mesh：

Substances：

Year:  1965        PMID： 14287841      PMCID： PMC1256300          DOI： 10.2105/ajph.55.5.703

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  4 in total

1.  Trial by anecdote.

Authors: 
Journal:  BMJ       Date:  1991-02-02

2.  The Need for Pediatric Drug Development.

Authors:  Robert M Ward; Daniel K Benjamin; Jonathan M Davis; Richard L Gorman; Ralph Kauffman; Gregory L Kearns; Mary Dianne Murphy; Catherine M T Sherwin
Journal:  J Pediatr       Date:  2017-09-21       Impact factor: 4.406

3.  Why the Watchdog Won't Bite: U.S. Food and Drug Administration Challenges.

Authors:  Joe Lex
Journal:  West J Emerg Med       Date:  2016-11-04

4.  Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.

Authors:  Rashmi R Shah
Journal:  Drug Saf Case Rep       Date:  2017-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.